These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 796848)

  • 21. THE IMMUNOGENICITY OF BCG (PHIPPS) AND ITS ISONIAZID-RESISTANT MUTANT IN GUINEA PIGS SIMULTANEOUSLY VACCINATED, INFECTED, AND TREATED.
    DWORSKI M
    Am Rev Respir Dis; 1964 Jul; 90():97-104. PubMed ID: 14180060
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 23. [Change of tuberculin sensitivity during involution of experimental pulmonary tuberculosis].
    Gavrilenko VS; Klebanova AA; Braude VI; Slonchak AT; Cherednichenko LP
    Probl Tuberk; 1974; (2):81-5. PubMed ID: 4457913
    [No Abstract]   [Full Text] [Related]  

  • 24. Incidence of resistant pulmonary tuberculosis in relation to initial bacterial load, Rifampicin and INH in experimental tuberculosis.
    Kradolfer F; Schnell R
    Chemotherapy; 1970; 15(4):242-9. PubMed ID: 4919029
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
    Frenette M; Portelance V; Beaudet R
    Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [VACCINAL POWER IN THE GUINEA PIG OF INH-RESISTANT BCG AND INH-RESISTANT BCG "LABELED" WITH RESISTANCE TO GRAMICIDIN].
    AUGIER J; BRETEY J; AUGIER-GIBORY S; BOISVERT H
    Ann Inst Pasteur (Paris); 1963 Nov; 105():937-48. PubMed ID: 14098103
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of early administration of isoniazid on the immunizing activity of normal BCG and isoniazid-resistant BCG in guinea pigs.
    BRETEY J; CANETTI G
    Am Rev Tuberc; 1957 Apr; 75(4):650-5. PubMed ID: 13411424
    [No Abstract]   [Full Text] [Related]  

  • 30. [STUDIES ON A HYDRAZIDE-RESISTANT STRAIN OF BCG MOREAU. III. VIRULENCE IN ANIMALS AND SOME PHYSIOLOGICAL CHARACTERISTICS].
    SITEK K
    Med Dosw Mikrobiol; 1963; 15():207-16. PubMed ID: 14062753
    [No Abstract]   [Full Text] [Related]  

  • 31. [LABORATORY STUDIES ON BCG VACCINE RESISTANT TO STREPTOMYCIN AND ISONIAZID ACTIVITY].
    BURACZEWSKA M; KURYLOWICZ W; PAKLERSKA-POBRATYN H
    Gruzlica (1926); 1964 Sep; 32():763-72. PubMed ID: 14249993
    [No Abstract]   [Full Text] [Related]  

  • 32. The attenuated W-115 strain of M. tuberculosis hominis and its isoniazid-resistant variant.
    Weissfeiler J; Karasseva V
    Am Rev Respir Dis; 1965 Dec; 92(6):870-6. PubMed ID: 4954268
    [No Abstract]   [Full Text] [Related]  

  • 33. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 34. Gene replacement in Mycobacterium bovis BCG.
    Norman E
    Methods Mol Biol; 1998; 101():225-33. PubMed ID: 9921482
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative study of the vaccinating properties of BCG and its isoniazid-resistant mutant in guinea pigs.
    SCHAEFER WB; COHN ML; MIDDLEBROOK G
    Am Rev Tuberc; 1957 Apr; 75(4):656-8. PubMed ID: 13411425
    [No Abstract]   [Full Text] [Related]  

  • 36. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VACCINATION EXPERIMENTS WITH INH-RESISTANT BCG.
    ENGBAEK HC; JESPERSEN A; RASMUSSEN KN; TOLDERLUNG K
    Acta Tuberc Pneumol Scand Suppl; 1964; 56():SUPPL 56:114-7. PubMed ID: 14160961
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histopathologic study of the experimental pathogenic power of isoniazid-resistant BCG: fresh or lyophilized catalase-positive B1 strain].
    Levaditi JC; Kosloff-Sénéchal F; Balouet G; Augier J
    Rev Tuberc Pneumol (Paris); 1966 Nov; 30(11):1168-75. PubMed ID: 4867685
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
    Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.